News - LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs
26 August 2024News - LGC appoints Marcus Kaeller as Chief Financial Officer
03 June 2024News - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project
22 February 2024News - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing
25 January 2024News - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes
15 January 2024News - LGC announces half year trading results
15 December 2023News - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.
14 November 2023News - National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.
02 November 2023News - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.
09 October 2023News - LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.
28 September 2023